Dana’s research explores the influence of prenatal and perinatal complications on the development of psychopathology. She is especially interested in how biomarkers may inform our understanding of the mechanisms that link these exposures with adverse neural development and poor psychological functioning. In particular, she is focused on understanding the impact of prenatal/perinatal oxygen deprivation and inflammation on the development of schizophrenia. Ultimately, her goal is to provide evidence that can be used to create interventions for high-risk infants that lower the risk of developing psychopathology.